Want to join the conversation?
$XEL 2Q15 PR: Operating revenues for 2Q15 were $2.52Bil vs. $2.69Bil in 2Q14. GAAP net income was $197MM, or $0.39 per share, vs. $195MM, or $0.39 per share, in 2Q14. Expect to deliver ongoing earnings within 2015 ongoing earnings guidance of $2.00 to $2.15 per share.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?